CARA Quote, Trading Chart, Cara Therapeutics Inc.
home / stock / cara / cara quote
$14.34 Last:
-1.44% Change Percent:
$14.58 Open:
$14.34 Previous Close:
$14.58 High:
$14.05 Low:
488,855 Volume:
06/21/2021 04:42:43 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CARA Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-21 | 14.58 | 14.34 | 14.58 | 14.05 | 488,855 |
| 2021-06-18 | 14.36 | 14.55 | 14.58 | 14.01 | 1,013,650 |
| 2021-06-17 | 14.72 | 14.65 | 15 | 14.59 | 481,652 |
| 2021-06-16 | 14.3 | 14.55 | 14.5899 | 14.15 | 877,208 |
| 2021-06-15 | 14.35 | 14.18 | 14.41 | 14.03 | 406,068 |
| 2021-06-14 | 14 | 14.36 | 14.38 | 14 | 566,037 |
| 2021-06-11 | 13.87 | 13.96 | 14.18 | 13.71 | 356,619 |
| 2021-06-10 | 13.83 | 13.86 | 14.09 | 13.7718 | 291,900 |
| 2021-06-09 | 13.57 | 13.83 | 14.09 | 13.57 | 510,464 |
| 2021-06-08 | 13.47 | 13.53 | 13.71 | 13.295 | 376,371 |
| 2021-06-07 | 13.03 | 13.47 | 13.65 | 12.98 | 565,188 |
| 2021-06-04 | 13.04 | 13 | 13.21 | 12.965 | 491,963 |
| 2021-06-03 | 13.19 | 13.06 | 13.27 | 12.98 | 599,318 |
| 2021-06-02 | 13.24 | 13.24 | 13.37 | 12.975 | 738,187 |
| 2021-06-01 | 13.7064 | 13.27 | 13.7064 | 12.97 | 770,431 |
| 2021-05-31 | 13.76 | 13.59 | 14.0105 | 13.55 | 378,173 |
| 2021-05-28 | 13.76 | 13.59 | 14.0105 | 13.55 | 374,987 |
| 2021-05-27 | 13.51 | 13.66 | 13.9 | 13.51 | 690,790 |
| 2021-05-26 | 13.3 | 13.6 | 13.63 | 13.28 | 463,666 |
| 2021-05-25 | 13.36 | 13.29 | 13.65 | 13.24 | 412,391 |
Cara Therapeutics Inc. Company Name:
CARA Stock Symbol:
NASDAQ Market:
Cara Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
SWK Holdings' Subsidiary, Enteris BioPharma, Receives $10 Million Milestone Payment from Cara Therapeutics Third milestone payment related to the development of Oral KORSUVA™ PR Newswire DALLAS , June 11, 2021 /PRNewswire/ -- SWK Holdings Corporation (...
-
Cara Therapeutics (NASDAQ: CARA) is an aspiring biotech company that seeks to combat an extremely common, yet under-the-radar, medical condition -- itchiness. Its efforts hit a stumbling block late last month, however, with the release of not-so-impressive clinical results for...
-
STAMFORD, Conn., May 25, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, today announc...